• Follow
  • Follow
  • Follow
  • Follow

Contact Us | Prescribing Info

  • What is Keratoconus?
    • Importance of Early Detection
  • What is Cross-Linking?
    • iLink™ FDA-Approved Cross-Linking
  • Insurance information
    • Cross-Linking & Insurance Guide
    • Copay Savings Program
  • Patient Resources
    • Keratoconus Journeys
    • Blog
    • World Keratoconus Day
  • Find an Expert
  • What is Keratoconus?
    • Importance of Early Detection
  • What is Cross-Linking?
    • iLink™ FDA-Approved Cross-Linking
  • Insurance information
    • Cross-Linking & Insurance Guide
    • Copay Savings Program
  • Patient Resources
    • Keratoconus Journeys
    • Blog
    • World Keratoconus Day
  • Find an Expert

Blog

What to Know About FDA Approved Treatments

November 24, 2021February 12, 2019 by Grace Lytle
Categories Blog, Grace Lytle

Daily Herald: Lehi teen undergoes the only FDA approved therapy for rare eye condition

November 24, 2021January 9, 2019 by Lauren

Ultimately, Jessa decided on the only FDA approved therapeutic cross-linking treatment to slow the progression of her keratoconus…

Categories Blog, Lauren McGuiggan

The Baltimore Sun: Ravens defensive tackle Brandon Williams receives FDA approved treatment to combat eye condition

November 24, 2021January 4, 2019 by Lauren
Categories Blog, Lauren McGuiggan

Feeling Confident While Living With Keratoconus

November 24, 2021December 27, 2018 by Lauren
Categories Blog, Lynn Gray

Hoover Sun: Hoover resident receives eye surgery for keratoconus

November 24, 2021December 17, 2018 by Lauren
Categories Blog, Lauren McGuiggan

WCVB Boston: Treatment option available for local family’s progressive eye disease

November 24, 2021December 11, 2018 by Lauren

WCVB recently highlighted the family’s journey with keratoconus, including Michael and Angelo’s decision to receive FDA-approved corneal cross-linking, a treatment that was not available when their mom was navigating her treatment options.

Categories Blog, Lauren McGuiggan

Richmond Magazine: Field of Vision

November 24, 2021November 20, 2018 by Lauren
Categories Blog, Lauren McGuiggan

Growing List of Commercial Plans Covering Avedro’s FDA-Approved Cross-Linking Procedure

November 24, 2021November 15, 2018 by Lauren
Categories Blog, Lauren McGuiggan

Understanding Insurance Coverage for Cross-Linking in the U.S.

November 24, 2021November 13, 2018 by Lauren
Categories Blog, Lynn Gray

World Keratoconus Day

November 24, 2021October 23, 2018 by Lauren
Categories Blog, Lauren McGuiggan, World KC Day
Post navigation
Older posts
Newer posts
← Previous Page1 … Page7 Page8 Page9 … Page11 Next →

Recent Posts

  • Playing Sports or Working Out With Keratoconus? Here’s What to Do!
  • KC Experts: Dr. Ostrovsky on Down Syndrome, Keratoconus and the Importance of Early Detection
  • Keratoconus Voices: Bringing Vision into Focus
  • Keratoconus Journey: Steven
  • Cross-Linking FAQ: Does Corneal Cross-Linking Help Vision?

Archives

Categories

Stay Connected

Sign up for our newsletter and get notifications sent directly to your inbox.

7 + 2 =

Recent Posts

Herald Democrat (Sherman, TX): Jackson Rainbow Enjoys Favorite Hobbies Again After Surgery Preserves Vision

Apr 1, 2021

“I love to hunt deer (and) duck. When you hunt a duck you can shoot with a shotgun. When you go to shoot the duck, I would have to squint my eyes to get a clear picture.” – Jackson Rainbow, age 22 Jackson is no stranger to chronic medical conditions. After...

Keratoconus Journey: Casey

Mar 15, 2021

Casey noticed his vision was blurry at just 15 years old. An initial diagnosis determined he had a cataract, but after undergoing the recommended corrective surgery, his vision only continued to decline. A second opinion found that he was in fact living with...

OD Expert – Tips on Caring for Scleral Lenses

Mar 5, 2021

If you or a loved one is living with keratoconus, you may be familiar with prescription contact lenses to help with blurry or distorted vision. Contact lenses are a common part of a person’s keratoconus journey and can range from soft contact lenses to Rigid Gas...

A Seasonal Guide to Allergies

Mar 1, 2021

Do you feel like you’re affected by allergies year-round? You’re not alone! Hay fever affects about 6.1 million children and 20 million adults. While many people associate allergy season with the fall or spring, few know there are different allergens that can make...

Contact Us

Headquarters
201 Jones Road
Waltham, MA 02451

Call us: (844) 528-3376
Send an Email

View our Privacy Policy and Terms of Use

© 2021 Living with Keratoconus. Glaukos® is a registered trademark of Glaukos Corporation. iLink™ is a trademark of Glaukos Corporation. Photrexa®, Photrexa® Viscous, and the KXL® system are registered trademarks of Avedro, a Glaukos company. All Rights Reserved. Glaukos Corporation.

  • Follow
  • Follow
  • Follow
  • Follow

IMPORTANT SAFETY INFORMATION

APPROVED USES
Photrexa® Viscous (riboflavin 5’-phosphate in 20% dextran ophthalmic solution) and Photrexa® (riboflavin 5’-phosphate ophthalmic solution) are used with the KXL® System in corneal cross-linking to treat eyes in which the cornea, the clear dome shaped surface that covers the front of the eye, has been weakened from the progression of the disease keratoconus or following refractive surgery, a method for correcting or improving your vision.

Tell your healthcare provider if you are pregnant or plan to become pregnant.

IMPORTANT SAFETY INFORMATION
Ulcerative keratitis, a potentially serious eye infection, can occur. Your doctor should monitor defects in the outermost corneal layer of the eye for resolution.

The most common ocular side effect is haze. Other ocular side effects include inflammation, fine white lines, dry eye, disruption of surface cells, eye pain, light sensitivity, reduced sharpness of vision, and blurred vision. The risk information provided here is not comprehensive. To learn more, talk to your healthcare provider.

Go to Prescribing Info to obtain the FDA-approved product labeling.

You are encouraged to report all side effects to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.